BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29427623)

  • 1. Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages.
    Deng Y; Yang Y; Yao B; Ma L; Wu Q; Yang Z; Zhang L; Liu B
    Exp Cell Res; 2018 Mar; 364(2):208-216. PubMed ID: 29427623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
    Zhang J; Li H; Wu Q; Chen Y; Deng Y; Yang Z; Zhang L; Liu B
    Redox Biol; 2019 Apr; 22():101116. PubMed ID: 30769285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer.
    Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y
    Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
    Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of VEGF-C and VEGFR-3 expression in non-small cell lung cancer.
    Li J; Hong M; Pan T
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):587-90. PubMed ID: 17219976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation 
in NSCLC Development].
    Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macrophage colony stimulating factor enhances non-small cell lung cancer invasion and metastasis by promoting macrophage M2 polarization].
    Li YJ; Yang L; Wang LP; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):412-418. PubMed ID: 28635229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer].
    Dong X; Qiu XS; Wang EH; Li QC; Gu W
    Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):128-32. PubMed ID: 12839674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
    Chen X; Xie Q; Cheng X; Diao X; Cheng Y; Liu J; Xie W; Chen Z; Zhu B
    Cancer Sci; 2010 Nov; 101(11):2384-90. PubMed ID: 20825419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
    Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
    J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
    Kang H; Zhang J; Wang B; Liu M; Zhao J; Yang M; Li Y
    Int J Oncol; 2017 Feb; 50(2):545-554. PubMed ID: 28101568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental Growth Factor Mediates Crosstalk Between Lung Cancer Cells and Tumor-Associated Macrophages in Controlling Cancer Vascularization and Growth.
    He C; Zhu K; Bai X; Li Y; Sun D; Lang Y; Ning J; Sun F; Qu C; Xu S
    Cell Physiol Biochem; 2018; 47(6):2534-2543. PubMed ID: 29991059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.
    Liu L; Ge D; Ma L; Mei J; Liu S; Zhang Q; Ren F; Liao H; Pu Q; Wang T; You Z
    J Thorac Oncol; 2012 Jul; 7(7):1091-100. PubMed ID: 22534817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
    Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
    Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.